Eton Pharmaceuticals Inc (ETON)
3.36
-0.20
(-5.62%)
USD |
NASDAQ |
Jun 17, 16:00
3.36
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Max Drawdown (5Y): 79.94% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 79.94% |
April 30, 2024 | 79.94% |
March 31, 2024 | 79.94% |
February 29, 2024 | 79.94% |
January 31, 2024 | 79.94% |
December 31, 2023 | 79.94% |
November 30, 2023 | 79.94% |
October 31, 2023 | 79.94% |
September 30, 2023 | 79.94% |
August 31, 2023 | 79.94% |
July 31, 2023 | 79.94% |
June 30, 2023 | 79.94% |
May 31, 2023 | 79.94% |
April 30, 2023 | 79.94% |
March 31, 2023 | 79.94% |
February 28, 2023 | 79.94% |
January 31, 2023 | 79.94% |
December 31, 2022 | 79.94% |
November 30, 2022 | 79.94% |
October 31, 2022 | 79.94% |
September 30, 2022 | 79.74% |
August 31, 2022 | 77.56% |
July 31, 2022 | 74.68% |
June 30, 2022 | 74.68% |
May 31, 2022 | 71.30% |
Date | Value |
---|---|
April 30, 2022 | 67.13% |
March 31, 2022 | 67.13% |
February 28, 2022 | 67.13% |
January 31, 2022 | 67.13% |
December 31, 2021 | 67.13% |
November 30, 2021 | 67.13% |
October 31, 2021 | 67.13% |
September 30, 2021 | 67.13% |
August 31, 2021 | 67.13% |
July 31, 2021 | 67.13% |
June 30, 2021 | 67.13% |
May 31, 2021 | 67.13% |
April 30, 2021 | 67.13% |
March 31, 2021 | 67.13% |
February 28, 2021 | 67.13% |
January 31, 2021 | 67.13% |
December 31, 2020 | 67.13% |
November 30, 2020 | 67.13% |
October 31, 2020 | 67.13% |
September 30, 2020 | 67.13% |
August 31, 2020 | 67.13% |
July 31, 2020 | 67.13% |
June 30, 2020 | 67.13% |
May 31, 2020 | 67.13% |
April 30, 2020 | 67.13% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
15.38%
Minimum
Jun 2019
79.94%
Maximum
Oct 2022
67.49%
Average
67.13%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Eli Lilly and Co | 22.48% |
Outlook Therapeutics Inc | 98.82% |
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -34.70 |
Beta (5Y) | 1.269 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.20% |
Historical Sharpe Ratio (5Y) | -0.2783 |
Historical Sortino (5Y) | -0.5258 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.07% |